A New Drug–Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study
- 3 June 2020
- journal article
- research article
- Published by Springer Nature in Drug Safety
- Vol. 43 (7) , 657-660
Abstract
Introduction Hydroxychloroquine was recently promoted in patients infected with COVID-19 infection. A recent experimental study has suggested an increased toxicity of hydroxychloroquine in association with metformin in mice. Objective The present study was undertaken to investigate the reality of this putative drug–drug interaction between hydroxychloroquine and metformin using pharmacovigilance data. Methods Using VigiBase®, the WHO pharmacovigilance database, we performed a disproportionality analysis (case/non-case study). Cases were reports of fatal outcomes with the drugs of interest and non-cases were all other reports for these drugs registered between 1 January 2000 and 31 December 2019. Data with hydroxychloroquine (or metformin) alone were compared with the association hydroxychloroquine + metformin. Results are reported as ROR (reporting odds ratio) with their 95% confidence interval. Results Of the 10,771 Individual Case Safety Reports (ICSR) involving hydroxychloroquine, 52 were recorded as ‘fatal outcomes’. In comparison with hydroxychloroquine alone, hydroxychloroquine + metformin was associated with an ROR value of 57.7 (23.9–139.3). In comparison with metformin alone, hydroxychloroquine + metformin was associated with an ROR value of 6.0 (2.6–13.8). Conclusion Our study identified a signal for the association hydroxychloroquine + metformin that appears to be more at risk of fatal outcomes (particularly by completed suicides) than one of the two drugs when given alone.Keywords
This publication has 12 references indexed in Scilit:
- Uses of pharmacovigilance databases: An overviewTherapies, 2020
- Fatal toxicity of chloroquine or hydroxychloroquine with metformin in micebioRxiv, 2020
- Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidenceBMJ, 2020
- Pharmacovigilance – The next chapterTherapies, 2019
- 1189-P: Effectiveness of Hydroxychloroquine (HCQ) 400 mg in Uncontrolled T2D Patients on Dual Therapy of Metformin and Sulfonylurea: A Real-World Experience in IndiaDiabetes, 2019
- The Potential Use of Metformin, Dipyridamole, N-Acetylcysteine and Statins as Adjunctive Therapy for Systemic Lupus ErythematosusCells, 2019
- Case–non-case studies: Principle, methods, bias and interpretationTherapies, 2019
- Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous DatabasesDrug Safety, 2016
- Comparison of Statistical Signal Detection Methods Within and Across Spontaneous Reporting DatabasesDrug Safety, 2015
- Detecting drug–drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugsEuropean Journal of Clinical Pharmacology, 2000